News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Ablynx (ABLYF) Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi (SNY)     7/20/2017
Roche (RHHBY) Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics     7/20/2017
Kite Pharma (KITE) Touts Remissions Up to 56+ Months in Non-Hodgkin Lymphoma Patients on CAR T-Cell Therapy     7/20/2017
Ironwood (IRWD)'s Potential Blockbuster Drug Meets Main Goals in Mid-Stage Trial     7/20/2017
Vertex (VRTX) Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials     7/19/2017
FDA Green Lights Gilead (GILD)'s Vosevi, With a Black Box Warning Attached     7/19/2017
Samsung Bioepis Emerging as a Strong Player in the Autoimmune Space     7/19/2017
Another Alzheimer's Let-Down as FUJIFILM's Candidate Flunks Phase II Test     7/19/2017
Puma Biotech (PBYI) Surges After the FDA Officially Approves Breast Cancer Drug     7/19/2017
Safety Issues Force the FDA to Turn Down Amgen (AMGN), UCB SA's Osteoporosis Drug     7/18/2017
FDA Gives Nod to Johnson & Johnson (JNJ)'s Potential Blockbuster Psoriasis Med     7/17/2017
Novartis AG (NVS) Stocking Up on "Big-3" Arthritis Blockbusters to Get an Edge on Rivals     7/14/2017
FDA Panel Unanimously Endorses Novartis AG (NVS)'s CAR-T Leukemia Drug     7/14/2017
Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's     7/13/2017
Why This Bay Area Pharma Could Win the Hemophilia Race With 'One And Done' Drug     7/13/2017

News from Around the Web
University of Pennsylvania Researchers Engineer Macrophages To Engulf Cancer Cells In Solid Tumors     7/20/2017
When It Comes To Abusive Drug Pricing, Don't Confuse Shkreli With Hep C Drugs     7/19/2017
Genentech (RHHBY) R&D Exec Reveals Alzheimer's is Still A Priority     7/19/2017
NanoVelcro Microchips Could Someday Noninvasively Diagnose Prenatal Conditions, ACS Nano Reveals     7/19/2017
Blood Test Identifies Key Alzheimer's Marker, Washington University School of Medicine Study Reveals     7/19/2017
Top 10 Therapeutic Areas In Biopharma R&D     7/18/2017
In Alzheimer's, The 'Juggernaut Is Changing Course,' Says TauRx Pharma Chief Exec     7/18/2017
Google (GOOG)'s Verily (GOOGL) Robots Just Released Millions Of Mosquitos In California     7/18/2017
New Device Detects Tumor Cells In Blood, Universitat Rovira i Virgili Study Reveals     7/18/2017
Breathable, Wearable Electronics On Skin For Long-Term Health Monitoring, University of Tokyo Study     7/18/2017
'Activity Inequality' Could Be One Of The Biggest Factors In Obesity, Stanford Study Reveals     7/17/2017
LivaNova (LIVN) Plant Linked to Heart Surgery Infections From Contaminated Medical Devices     7/14/2017
Science May Just Have Found A Way To Treat The Flu And Common Cold, Nature Communications Reveals     7/13/2017
Antibiotic Nanoparticles Fight Drug-Resistant Bacteria, Advanced Materials Reveals     7/13/2017
Why Eli Lilly (LLY) Is Gouging Diabetes Drug Share From Dow's Johnson & Johnson (JNJ), Others     7/11/2017

Press Releases
Theravance Biopharma (TBPH) AndMylan (MYL) Announce Positive Results From 12-Month Phase III Safety Study Of Revefenacin (TD-4208) In Patients With Chronic Obstructive Pulmonary Disease (COPD)     7/20/2017
Aerie (AERI) Reports Positive Roclatan™ (Netarsudil/Latanoprost Ophthalmic Solution) 0.02%/0.005% Phase III 12-Month Topline Safety Results     7/20/2017
Angle: Preclinical Study Presented At Tumor Boston Summit     7/20/2017
BiondVax's Universal Flu Vaccine Meets All Endpoints in Phase IIb Study     7/20/2017
Braeburn Pharma And Camurus Announce Submission Of NDA For Long-Acting Buprenorphine (CAM2038) For Opioid Use Disorder     7/20/2017
Churchill Pharmaceuticals Announces NDA Filing Acceptance For YONSA By The U.S. FDA     7/20/2017
LEO Pharma Receives Marketing Authorisation For Kyntheum (Brodalumab), A New Biologic For The Treatment Of Moderate-To-Severe Plaque Psoriasis In The European Union     7/20/2017
Merck & Co. (MRK) Announces U.S. FDA Grants Tentative Approval For LUSDUNA™ Nexvue™ (Insulin Glargine Injection), A Follow-On Biologic Basal Insulin     7/20/2017
Teva (TEVA) Release: NICE Recommends CINQAERO (Reslizumab) For The Treatment Of Severe Eosinophilic Asthma     7/20/2017
Spark Therapeutics (ONCE) Receives Rare Pediatric Disease Designation For Investigational LUXTURNA (Voretigene Neparvovec) From FDA     7/20/2017
U.S. FDA Grants Orphan-Drug Designation To Astellas (ALPMY) For Development Of FLT3 Inhibitor Gilteritinib In Acute Myeloid Leukemia     7/20/2017
Incyte (INCY) Announces First Patient Treated In Phase III Clinical Trial Of Itacitinib For Acute Graft-Versus-Host Disease     7/20/2017
Diffusion Pharma Achieves Drug Production Milestone For Planned Phase III Clinical Trial In Inoperable GBM Brain Cancer     7/20/2017
Kamada (KMDA) Submits Proposed Phase III Protocol To FDA For Inhaled Alpha-1 Antitrypsin For Treatment Of Alpha-1 Antitrypsin Deficiency Disease     7/20/2017
Celyad Announces Initiation Of The SHRINK Trial     7/20/2017